Advanced Search
Korean J Pediatr 2018 February;61(2) :37-42.
Published online 2018 February 15.       
Atypical hemolytic uremic syndrome and eculizumab therapy in children
Seong Heon Kim1, Hye Young Kim2, Su Young Kim1
1Department of Pediatrics, Pusan National University Childrens Hospital, Yangsan, Korea
2Department of Pediatrics, Pusan National University Hospital, Busan, Korea
Corresponding Author: Su Young Kim ,Tel: +82-55-360-3151, Fax: +82-55-360-2181, Email:
Copyright © 2018 by The Korean Pediatric Society
Hemolytic uremic syndrome (HUS) is often encountered in children with acute kidney injury. Besides the well-known shiga toxin-producing Escherichia coli-associated HUS, atypical HUS (aHUS) caused by genetic complement dysregulation has been studied recently. aHUS is a rare, chronic, and devastating disorder that progressively damages systemic organs, resulting in stroke, end-stage renal disease, and death. The traditional treatment for aHUS is mainly plasmapheresis or plasma infusion; however, many children with aHUS will progress to chronic kidney disease despite plasma therapy. Eculizumab is a newly developed biologic that blocks the terminal complement pathway and has been successfully used in the treatment of aHUS. Currently, several guidelines for aHUS, including the Korean guideline, recommend eculizumab as the first-line therapy in children with aHUS. Moreover, life-long eculizumab therapy is generally recommended. Further studies on discontinuation of eculizumab are needed.
Keywords: Atypical hemolytic uremic syndrome | Child | Eculizumab | Plasma therapy | Guideline
PDF Links  PDF Links
Full text via DOI  Full text via DOI
Download Citation  Download Citation
Supplementary Material  Supplementary Material
A case of hemolytic uremic syndrome preceded by intussusception  2011 April;54(4)
A case of atypical hemolytic uremic syndrome as an early manifestation of acute lymphoblastic leukemia  2010 February;53(2)
The myocarditis and cardiomyopathy in children  2007 November;50(11)
Hemolytic uremic syndrome  2007 October;50(10)
A clinical study of systemic lupus erythematosus in children  2007 January;50(1)
Register for e-submission
Register here to access the e-submission system of Korean J Pediatr for authors and reviewers.
Manuscript Submission
To submit a manuscript, please visit the Korean J Pediatr e-submission management system at, read the Instructions for Authors, and log into the Korean J Pediatr e-submission system. For assistance with manuscript submission, please contact:
Free archive
Anyone may access any past or current articles without logging in.
Korean Pediatric Society Office
#1606, Seocho World Officetel, 19 Seoun-ro, Seocho-gu, Seoul 137-070, Korea
TEL : +82-2-3473-7305    FAX : +82-2-3473-7307   E-mail:
BrowseCurrent IssueFor Authors and ReviewersAbout
Copyright© The Korean Pediatric Society. All right reserved.